Innovating Access to Medicine in Kenya

Take an inside look into Novartis Access, a program that provides medicines to developing countries, like Kenya, for approximately one US dollar for one month’s treatment. The program currently provides medicines for noncommunicable diseases (NCD) such as cardiovascular diseases, diabetes and cancer, which cause 28 million deaths in low- and middle-income countries each year.

In Kenya, the average revenue per person is 100 dollars per month with almost half the population below the poverty line, which is why Novartis Access is seeking to establish the program long-term. The program is expected to reach 20 million people by 2020.

According to the Novartis Access global lead, Harald Nusser, “the concept [of the program] is unprecedented. This is a really broad portfolio approach targeting almost the universe of non-communicable diseases, which are life-threatening.” Watch how Novartis Access is working to change the lives of people in Kenya one medicine at a time.

To learn more about our work in Kenya, follow the story of two of our employees who traveled to Kenya to make a global impact through health education and services.

From Canada to Kenya: Two Employees Embark on a Special Mission

From Canada to Kenya: Two Employees Embark on a Special Mission

Follow the journey of two Novartis employees from Canada who traveled to Kenya to make a global impact through health education and services.

read more
Novartis Pharma Global Tropical Medicines Head visits a clinic in Kenya.

3 Days in Kenya with the Head of Novartis Tropical Medicines in the Novartis Malaria Initiative

Malaria remains a global health epidemic despite being both preventable and treatable. A Novartis team including global Tropical Medicines head Roger Waltzman traveled to Kenya to support malaria prevention and treatment.

read more
Building Scientific Capability in Developing Countries

Building Scientific Capability in Developing Countries

The director of the Next Generation Scientists program describes helping young scientists from developing countries bring new skills and knowledge home.

read more

You are now visiting a new site to which our Privacy Policy does not apply. You are solely responsible for your interactions with that website.

Cancel | Continue

Novartis logo